News
Awards acknowledge the abilities of many outstanding federal healthcare individuals each year. Read More ›
In October 2024, officials with the CDC dropped the initial age at which adults are recommended to get vaccinated against pneumococcal disease, from 65 to 50 years, Goad noted. Read More ›
At the exhibition hall at the seminar, key leaders with ImPACT Federal Health met with dozens of seminar attendees, and discussed this print and digital publication, which aims to provide best practices, discussion forums, and the latest clinical news to help physicians, pharmacists, nurse practitioners, and physician assistants in federal healthcare overcome medical and commercial challenges to deliver best-in-class care to our nation’s heroes and their families Read More ›
There is a “significant” link between toxic exposures during military service and the prevalence of lung cancer among veterans, according to a study presented at the International Association for the Study of Lung Cancer (IASLC)’s 2024 World Conference on Lung Cancer. Read More ›
The acceleration of technology in the healthcare sector has been helpful in streamlining many aspects of day-to-day operations, but new innovations continue apace, including customer relationship management software, business intelligence tools, artificial intelligence, and updated electronic medical records and telehealth systems. Read More ›
This new feature aims to provide ongoing lists of US-based phase 2 or 3 clinical trials that are actively recruiting, and it can be used to encourage patients to enroll in a clinical trial. This issues feature is focused on sarcoma. Read More ›
Despite ranking among the top 6 wealthiest economies in the world per capita, the United States still has sizable health disparities among its citizens, which are rooted in social, economic, and environmental factors. A comprehensive local approach was developed at Carolina Blood and Cancer Care Associates to include support from all segments of the health ecosystem. Read More ›
While the panel acknowledged there is a long way to go in terms of encouraging diverse patient populations to participate in clinical trials, they note that there is reason for hope. Before the draft guidance was even issued by the FDA in June, several industry sponsors had already partnered with health care professionals to boost clinical trial participation. Read More ›
Shield, Guardant Health has been FDA approved and is now covered by Medicare as the first blood test for primary colorectal cancer (CRC) screening. Read More ›
On June 26, 2024, the FDA approved epcoritamab-bysp (Epkinly; Abbvie and Genmab) as the first and only T-cell engaging bispecific antibody administered subcutaneously for the treatment of adults with relapsed or refractory follicular lymphoma (FL) after ≥2 lines of prior therapy. Read More ›